Top

Published in:

01-04-2015 | Case report

Sorafenib

Hand-foot syndrome, diarrhoea, and dyspepsia: 7 case reports

Published in: Reactions Weekly | Issue 1/2015

Excerpt

Seven patients, 6 men and 1 woman, developed either hand-foot syndrome or diarrhoea or dyspepsia, or combinations of these reactions, following treatment with sorafenib, at a starting dose of 400mg twice daily, for recurrent hepatocellular carcinoma following liver transplantation [duration of treatment to reaction onsets and outcomes not stated]. …

Pfeiffenberger J, et al. Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. Langenbecks Archives of Surgery 398: 1123-1128, No. 8, Dec 2013 - GermanyCrossRef

Title: Sorafenib
Hand-foot syndrome, diarrhoea, and dyspepsia: 7 case reports
Publication date: 01-04-2015
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9314-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sorafenib

Hand-foot syndrome, diarrhoea, and dyspepsia: 7 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Methylprednisolone acetate

Mesalazine

Zidovudine

Epirubicin/cyclophosphamide/trastuzumab

Paracetamol

Lamotrigine